Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Meisner

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Health Economics|May 1, 1997
Statistical inference for cost-effectiveness ratiosE M Laska, M Meisner, C Siegel
Biometrics|December 1, 1983
Optimal crossover designs in the presence of carryover effectsE Laska, M Meisner, H B Kushner
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 29, 1999
Power and sample size in cost-effectiveness analysisE M Laska, M Meisner, C Siegel
Journal of Theoretical Biology|May 21, 1977
A paradox in the prognosis of schizophrenia. explanation by a mathematical modelM Branchey, M Meisner, G M Simpson
Health Economics|November 14, 1997
The usefulness of average cost-effective ratiosE M Laska, M Meisner, C Siegel
Biometrics|September 1, 1994
Simple designs and model-free tests for synergyE M Laska, M Meisner, C Siegel
British Journal of Pharmacology|November 1, 1994
Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-yl-xanthogenate (D609)K Tschaikowsky, M Meisner, F Schönhuber, et al.
Statistics in Medicine|October 23, 1997
Classification of the effectiveness of combination treatmentsE M Laska, M Meisner, D I Tang
International Journal of Immunopharmacology|February 24, 2000
Influence of pyrrolidine dithiocarbamate on the inflammatory response in macrophages and mouse endotoxin shockM Meisner, J Schmidt, M Schywalsky, et al.
Intensive Care Medicine|May 13, 2008
The natural elimination rate of procalcitonin in patients with normal and impaired renal functionM Meisner, J Schmidt, H Hüttner, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Health Economics|May 1, 1997
Statistical inference for cost-effectiveness ratiosE M Laska, M Meisner, C Siegel
Biometrics|December 1, 1983
Optimal crossover designs in the presence of carryover effectsE Laska, M Meisner, H B Kushner
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 29, 1999
Power and sample size in cost-effectiveness analysisE M Laska, M Meisner, C Siegel
Journal of Theoretical Biology|May 21, 1977
A paradox in the prognosis of schizophrenia. explanation by a mathematical modelM Branchey, M Meisner, G M Simpson
Health Economics|November 14, 1997
The usefulness of average cost-effective ratiosE M Laska, M Meisner, C Siegel
Biometrics|September 1, 1994
Simple designs and model-free tests for synergyE M Laska, M Meisner, C Siegel
British Journal of Pharmacology|November 1, 1994
Induction of nitric oxide synthase activity in phagocytic cells inhibited by tricyclodecan-9-yl-xanthogenate (D609)K Tschaikowsky, M Meisner, F Schönhuber, et al.
Statistics in Medicine|October 23, 1997
Classification of the effectiveness of combination treatmentsE M Laska, M Meisner, D I Tang
International Journal of Immunopharmacology|February 24, 2000
Influence of pyrrolidine dithiocarbamate on the inflammatory response in macrophages and mouse endotoxin shockM Meisner, J Schmidt, M Schywalsky, et al.
Intensive Care Medicine|May 13, 2008
The natural elimination rate of procalcitonin in patients with normal and impaired renal functionM Meisner, J Schmidt, H Hüttner, et al.
Pageof 6